Sea Lice Exposure to Non-lethal Levels of Emamectin Benzoate After Treatments: a Potential Risk Factor for Drug Resistance

Overview

Journal Sci Rep

Specialty Science

Date 2020 Jan 24

PMID 31969584

Citations 5

Authors

Chun Ting Lam

Sarah M Rosanowski

Martin Walker

Sophie St-Hilaire

Affiliations

Soon will be listed here.

Abstract

The avermectin derivative emamectin benzoate (EMB) has been widely used by salmon industries around the world to control sea lice infestations. Resistance to this anti-parasitic drug is also commonly reported in these industries. The objective of this study was to quantify the number of sea lice potentially exposed to sub-lethal concentrations of EMB while fish clear the drug after treatments. We assessed juvenile sea lice abundance after 38 EMB treatments on six Atlantic salmon farms, in a small archipelago in British Colombia, Canada, between 2007 and 2018. We fitted a standard EMB pharmacokinetic curve to determine the time when fish treated with this product would have EMB tissue concentrations below the recommended target therapeutic level. During the study, we estimated that for each sea lice treatment there was, on average, an abundance of 0.12 juvenile sea lice per fish during the time period when the concentrations of EMB would have been lower than 60ppb, the recommended therapeutic treatment level for sea lice. The findings from this study on metaphylactic anti-parasitic treatments identify a potential driver for drug resistance in sea lice that should be further explored.

Citing Articles

Insights from Hi-C data regarding the Pacific salmon louse (Lepeophtheirus salmonis) sex chromosomes.

Flores A, Christensen K, Siah A, Koop B G3 (Bethesda). 2024; 14(7).

PMID: 38683737 PMC: 11228835. DOI: 10.1093/g3journal/jkae087.

Biosafety, histological alterations and residue depletion of feed administered anti-parasitic drug emamectin benzoate in golden mahseer, (Hamilton, 1822) as a model candidate fish for sport fishery and conservation in temperate waters.

Mallik S, Singh S, Shahi N, Patil P, Kala K, Pathak R Front Pharmacol. 2023; 14:1106124.

PMID: 36843939 PMC: 9950520. DOI: 10.3389/fphar.2023.1106124.

Salmon lice in the Pacific Ocean show evidence of evolved resistance to parasiticide treatment.

Godwin S, Bateman A, Kuparinen A, Johnson R, Powell J, Speck K Sci Rep. 2022; 12(1):4775.

PMID: 35347162 PMC: 8960799. DOI: 10.1038/s41598-022-07464-1.

Characterization of miRNAs in Embryonic, Larval, and Adult Lumpfish Provides a Reference miRNAome for .

Chakraborty S, Woldemariam N, Visnovska T, Rise M, Boyce D, Santander J Biology (Basel). 2022; 11(1).

PMID: 35053128 PMC: 8773022. DOI: 10.3390/biology11010130.

Emamectin Benzoate Treatment of Hybrid Grouper Infected With Sea Lice in Hong Kong.

St-Hilaire S, Cheng T, Chan S, Leung C, Chan K, Lim K Front Vet Sci. 2021; 8:646652.

PMID: 33644159 PMC: 7907643. DOI: 10.3389/fvets.2021.646652.

References

Jones P, Hammell K, Dohoo I, Revie C . Effectiveness of emamectin benzoate for treatment of Lepeophtheirus salmonis on farmed Atlantic salmon Salmo salar in the Bay of Fundy, Canada. Dis Aquat Organ. 2012; 102(1):53-64. DOI: 10.3354/dao02517. View

Kristoffersen A, Rees E, Stryhn H, Ibarra R, Campisto J, Revie C . Understanding sources of sea lice for salmon farms in Chile. Prev Vet Med. 2013; 111(1-2):165-75. DOI: 10.1016/j.prevetmed.2013.03.015. View

Westcott J, Stryhn H, Burka J, Hammell K . Optimization and field use of a bioassay to monitor sea lice Lepeophtheirus salmonis sensitivity to emamectin benzoate. Dis Aquat Organ. 2008; 79(2):119-31. DOI: 10.3354/dao01887. View

Saksida S, Morrison D, McKenzie P, Milligan B, Downey E, Boyce B . Use of Atlantic salmon, Salmo salar L., farm treatment data and bioassays to assess for resistance of sea lice, Lepeophtheirus salmonis, to emamectin benzoate (SLICE(®) ) in British Columbia, Canada. J Fish Dis. 2012; 36(5):515-20. DOI: 10.1111/jfd.12018. View

Sevatdal S, Magnusson A, Ingebrigtsen K, Haldorsen R, Horsberg T . Distribution of emamectin benzoate in Atlantic salmon (Salmo salar L.). J Vet Pharmacol Ther. 2005; 28(1):101-7. DOI: 10.1111/j.1365-2885.2004.00629.x. View

Glover K, Samuelsen O, Skilbrei O, Boxaspen K, Lunestad B . Pharmacokinetics of emamectin benzoate administered to Atlantic salmon, Salmo salar L., by intra-peritoneal injection. J Fish Dis. 2009; 33(2):183-6. DOI: 10.1111/j.1365-2761.2009.01099.x. View

Crouch L, Bova A, Robinson R, Wu J . Determination of emamectin residues in the tissues of Atlantic salmon (Salmo salar L.) using HPLC with fluorescence detection. J Agric Food Chem. 2001; 49(11):5294-302. DOI: 10.1021/jf010810+. View

Aarestrup F, Agerso Y, Gerner-Smidt P, Madsen M, Jensen L . Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn Microbiol Infect Dis. 2000; 37(2):127-37. DOI: 10.1016/s0732-8893(00)00130-9. View

Hayes J, English L, Carter P, Proescholdt T, Lee K, Wagner D . Prevalence and antimicrobial resistance of enterococcus species isolated from retail meats. Appl Environ Microbiol. 2003; 69(12):7153-60. PMC: 309953. DOI: 10.1128/AEM.69.12.7153-7160.2003. View

10.

Wegener H . Antibiotics in animal feed and their role in resistance development. Curr Opin Microbiol. 2003; 6(5):439-45. DOI: 10.1016/j.mib.2003.09.009. View

11.

Done H, Venkatesan A, Halden R . Does the Recent Growth of Aquaculture Create Antibiotic Resistance Threats Different from those Associated with Land Animal Production in Agriculture?. AAPS J. 2015; 17(3):513-24. PMC: 4406955. DOI: 10.1208/s12248-015-9722-z. View

12.

Scott A, Beller E, Glasziou P, Clark J, Ranakusuma R, Byambasuren O . Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review. Int J Antimicrob Agents. 2018; 52(3):316-323. DOI: 10.1016/j.ijantimicag.2018.04.005. View

13.

Baharoglu Z, Mazel D . SOS, the formidable strategy of bacteria against aggressions. FEMS Microbiol Rev. 2014; 38(6):1126-45. DOI: 10.1111/1574-6976.12077. View

14.

Long H, Miller S, Strauss C, Zhao C, Cheng L, Ye Z . Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proc Natl Acad Sci U S A. 2016; 113(18):E2498-505. PMC: 4983809. DOI: 10.1073/pnas.1601208113. View

15.

Gottesfeld A, PROCTOR B, Rolston L, Carr-Harris C . Sea lice, Lepeophtheirus salmonis, transfer between wild sympatric adult and juvenile salmon on the north coast of British Columbia, Canada. J Fish Dis. 2009; 32(1):45-57. DOI: 10.1111/j.1365-2761.2008.01003.x. View

16.

Jansen P, Kristoffersen A, Viljugrein H, Jimenez D, Aldrin M, Stien A . Sea lice as a density-dependent constraint to salmonid farming. Proc Biol Sci. 2012; 279(1737):2330-8. PMC: 3350688. DOI: 10.1098/rspb.2012.0084. View

17.

Salama N, Murray A, Rabe B . Simulated environmental transport distances of Lepeophtheirus salmonis in Loch Linnhe, Scotland, for informing aquaculture area management structures. J Fish Dis. 2015; 39(4):419-28. DOI: 10.1111/jfd.12375. View

18.

McEwan G, Groner M, Fast M, Gettinby G, Revie C . Using Agent-Based Modelling to Predict the Role of Wild Refugia in the Evolution of Resistance of Sea Lice to Chemotherapeutants. PLoS One. 2015; 10(10):e0139128. PMC: 4618729. DOI: 10.1371/journal.pone.0139128. View

19.

Aaen S, Helgesen K, Bakke M, Kaur K, Horsberg T . Drug resistance in sea lice: a threat to salmonid aquaculture. Trends Parasitol. 2015; 31(2):72-81. DOI: 10.1016/j.pt.2014.12.006. View

20.

Arriagada G, Stryhn H, Sanchez J, Vanderstichel R, Campisto J, Rees E . Evaluating the effect of synchronized sea lice treatments in Chile. Prev Vet Med. 2016; 136:1-10. DOI: 10.1016/j.prevetmed.2016.11.011. View